Janus Henderson Group’s GoodRx Holdings GDRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$63.8K Hold
32,452
﹤0.01% 2402
2025
Q4
$87.8K Hold
32,452
﹤0.01% 2398
2025
Q3
$137K Hold
32,452
﹤0.01% 2376
2025
Q2
$162K Hold
32,452
﹤0.01% 2360
2025
Q1
$146K Hold
32,452
﹤0.01% 2421
2024
Q4
$151K Hold
32,452
﹤0.01% 2477
2024
Q3
$226K Hold
32,452
﹤0.01% 2391
2024
Q2
$253K Sell
32,452
-450
-1% -$3.33K ﹤0.01% 2292
2024
Q1
$233K Buy
32,902
+46
+0.1% +$304 ﹤0.01% 2350
2023
Q4
$220K Buy
32,856
+14
+0% +$79 ﹤0.01% 2397
2023
Q3
$185K Sell
32,842
-7
-0% -$47 ﹤0.01% 2405
2023
Q2
$181K Sell
32,849
-66
-0.2% -$355 ﹤0.01% 2472
2023
Q1
$206K Buy
32,915
+16,396
+99% +$91.4K ﹤0.01% 2480
2022
Q4
$76.9K Sell
16,519
-16,517
-50% -$81.4K ﹤0.01% 2378
2022
Q3
$154K Buy
33,036
+16,470
+99% +$104K ﹤0.01% 2448
2022
Q2
$98K Buy
+16,566
New +$184K ﹤0.01% 2474
2021
Q2
Sell
-82,714
Closed -$3.23M 1631
2021
Q1
$3.23M Buy
82,714
+20,734
+33% +$932K ﹤0.01% 1096
2020
Q4
$2.5M Buy
+61,980
New +$2.85M ﹤0.01% 1092

Other funds holding GDRX

Janus Henderson Group's GDRX Position: Q1 2026 in Review

Janus Henderson Group held its GoodRx Holdings (GDRX) position steady in Q1 2026 at 32,452 shares worth $63.8K. The position accounts for ﹤0.01% of the portfolio, ranked #2402.

Janus Henderson Group first reported a position in GDRX in Q4 2020 and has held it in 18 quarters since. The position peaked at $3.23M in Q1 2021. 174 funds tracked by Wall St. Rank hold GDRX as of Q1 2026.

  • Janus Henderson Group held 32,452 shares of GoodRx Holdings worth $63.8K as of Q1 2026.
  • Janus Henderson Group left its GoodRx Holdings share count unchanged in Q1 2026.
  • GoodRx Holdings made up ﹤0.01% of Janus Henderson Group's portfolio in Q1 2026, its #2402 holding.
  • Janus Henderson Group first reported a position in GoodRx Holdings in Q4 2020 and has held it in 18 quarters since.
  • Janus Henderson Group's GoodRx Holdings position peaked at $3.23M in Q1 2021.
  • 174 funds tracked by Wall St. Rank held GoodRx Holdings as of Q1 2026.

Based on Janus Henderson Group's 13F filing for Q1 2026, filed 15 May 2026.